Temozolomide and oral etoposide in children with recurrent malignant brain tumors
The article reviews the results
derived from the combination use of TMZ and oral VP-16 to treat malignant brain tumors
The article reviews the results
derived from the combination use of TMZ and oral VP-16 to treat malignant brain tumors
Glioblastoma (GB) treatment remains challenging because of recurrence and poorly defined treatment options after first-line therapy. To better understand real-world application of treatment paradigms and their impact on outcomes, the authors describe patterns of GB treatment, outcomes, and use of cancer-related healthcare resource in the USA.